| 製品名 | Topiramate |
|---|---|
| CAS番号 | 97240-79-4 |
| 分子式 | C12H21NO8S |
| 分子量 | 339.36 |
| 外観 | 白色の結晶性粉末 |
| 分析(HPLC) | 98.0% ~ 101.0% |
| 乾燥減量 | ≤ 0.5% |
| 焼失残渣 | ≤ 0.1% |
| 重金属 | 10 ppm以下 |
| 融点 | 125°C ~ 130°C |
| 比回転 | [α]D20 = -30.0° ~ -34.0° (c=1, methanol) |
お困りですか? 弊社チームまでお問い合わせください
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate, Topamax, Epitomax, Topamac, TopiLEPTIN, Topiramic acid, RWJ-17021, McN-4853
Topiramate is a sulfamate-substituted monosaccharide that functions as a broad-spectrum antiepileptic agent. It is structurally distinct from other anticonvulsants, featuring a sulfamate group attached to a fructopyranose derivative. This unique structure contributes to its multifaceted mechanism of action, which includes modulation of voltage-gated sodium channels, enhancement of GABA-A receptor activity, and inhibition of carbonic anhydrase isozymes. These actions collectively stabilize neuronal membranes and reduce excitability, making it effective in managing partial-onset and generalized seizures.
Beyond its established role in epilepsy, topiramate is widely utilized in the prophylaxis of migraine headaches and has demonstrated efficacy in weight management when combined with phentermine. Its neurostabilizing properties have also been explored in psychiatric conditions such as bipolar disorder and post-traumatic stress disorder. The compound is well-absorbed orally, exhibits linear pharmacokinetics, and has a favorable safety profile, though dose titration is recommended to minimize adverse effects like paresthesia and cognitive slowing.